Technical artifacts in magnetic resonance imaging

Autor: W S, Yamanashi, K K, Wheatley, P D, Lester, D W, Anderson

Publikováno v: Physiological chemistry and physics and medical NMR. 16(3)

Various artifacts of Magnetic Resonance Imaging (MRI) typically associated with currently available imaging techniques such as projection reconstruction and two-dimensional fourier transform (2D-FT) are described and illustrated. Examples of MRI arti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ab80761e77c1691e45de50e4cfec3e89
https://pubmed.ncbi.nlm.nih.gov/6514817

A Randomised Phase II Trial to Evaluate the Feasibility of Radiotherapy Dose Escalation, Facilitated by Intensity-Modulated Arc Radiotherapy Techniques, in High-Risk Neuroblastoma.

Autor: Gains JE; Department of Oncology, University College London Hospitals NHS Foundation Trust, London, UK., Patel A; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Chang YC; Department of Oncology, University College London Hospitals NHS Foundation Trust, London, UK., Mandeville HC; Department of Radiotherapy, The Royal Marsden NHS Foundation Trust, Sutton, UK., Smyth G; National Radiotherapy Trials Quality Assurance Group, The Royal Marsden NHS Foundation Trust, Sutton, UK., Stacey C; Radiotherapy Physics Group, University College London Hospitals NHS Foundation Trust, London, UK., Talbot J; Department of Radiotherapy, The Royal Marsden NHS Foundation Trust, Sutton, UK., Wheatley K; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK., Gaze MN; Department of Oncology, University College London Hospitals NHS Foundation Trust, London, UK. Electronic address: https://twitter.com/@MarkGaze.

Publikováno v: Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2024 Jun; Vol. 36 (6), pp. e154-e162. Date of Electronic Publication: 2024 Mar 15.

Investigating the heterogeneity of alkylating agents' efficacy and toxicity between sexes: A systematic review and meta-analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study).

Autor: Fresneau B; Department of Pediatric oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Hackshaw A; Cancer Research UK & UCL Cancer Trials Centre, University College London, London, United Kingdom., Hawkins DS; Division of Hematology/Oncology, Department of Pediatrics, Seattle Children's Hospital, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington., Paulussen M; Vestische Kinder-und Jugendklinik Datteln, Witten/Herdecke University, Datteln, Germany., Anderson JR; Merck Research Laboratories-Oncology, North Wales, Pennsylvania., Judson I; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Litière S; Statistics Department, EORTC Headquarters, Brussels, Belgium., Dirksen U; Department of Pediatric Hematology and Oncology, University Hospital, Muenster, Germany., Lewis I; Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom., van den Berg H; Emma Children's Hospital/Academic Medical Center, Amsterdam, The Netherlands., Gaspar N; Department of Pediatric oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Whelan J; Cancer Medicine and Consultant Medical Oncologist, The London Sarcoma Service, University College Hospital, London, United Kingdom., Boddy AV; Faculty of Pharmacy, University of Sydney, Sydney, Australia., Wheatley K; Cancer Research UK, Cancer Trials Unit, University of Birmingham, Birmingham, United Kingdom., Pignon JP; Departments of Biostatistics and Epidemiology, Gustave-Roussy, Paris, France.; Paris-Saclay and Paris-SudUniversities, CESP, INSERM, Villejuif, France.; Gustave Roussy, Ligue Nationale Contre le Cancer Meta-analysis Platform, Villejuif, France., De Vathaire F; Radiation EpidemiologyGroup, INSERM, UMR1018, Villejuif, France., Le Deley MC; Departments of Biostatistics and Epidemiology, Gustave-Roussy, Paris, France.; Paris-Saclay and Paris-SudUniversities, CESP, INSERM, Villejuif, France., Le Teuff G; Departments of Biostatistics and Epidemiology, Gustave-Roussy, Paris, France.; Paris-Saclay and Paris-SudUniversities, CESP, INSERM, Villejuif, France.; Gustave Roussy, Ligue Nationale Contre le Cancer Meta-analysis Platform, Villejuif, France.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2017 Aug; Vol. 64 (8). Date of Electronic Publication: 2017 Jan 23.

Effect of topical imiquimod as primary treatment for lentigo maligna: the LIMIT-1 study.

Autor: Marsden JR; University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital, Edgbaston, Birmingham, B15 2TH, U.K., Fox R; Cancer Research U.K. Clinical Trials Unit, School of Cancer Sciences, The University of Birmingham, Edgbaston, Birmingham, B15 2TT, U.K., Boota NM; Nottingham Clinical Trials Unit, University of Nottingham, Nottingham, U.K., Cook M; Royal Surrey County Hospital, Guildford, U.K., Wheatley K; Cancer Research U.K. Clinical Trials Unit, School of Cancer Sciences, The University of Birmingham, Edgbaston, Birmingham, B15 2TT, U.K., Billingham LJ; Cancer Research U.K. Clinical Trials Unit, School of Cancer Sciences, The University of Birmingham, Edgbaston, Birmingham, B15 2TT, U.K., Steven NM; Cancer Research U.K. Clinical Trials Unit, School of Cancer Sciences, The University of Birmingham, Edgbaston, Birmingham, B15 2TT, U.K.

Publikováno v: The British journal of dermatology [Br J Dermatol] 2017 May; Vol. 176 (5), pp. 1148-1154. Date of Electronic Publication: 2017 Apr 10.

Treatment Reasons, Resource use and Costs of Hospitalisations in People with Parkinson's: Results from a Large Rct.

Autor: Xin Y; University of Glasgow, Glasgow, UK., Clarke CE; University of Birmingham, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK., Muzerengi S; University of Birmingham, Birmingham, UK., Rick CE; University of Birmingham, Birmingham, UK., Gray A; University of Oxford, Oxford, UK., Gray R; University of Oxford, Oxford, UK., Wheatley K; University of Birmingham, Birmingham, UK., Ives N; University of Birmingham, Birmingham, UK., McIntosh E; University of Glasgow, Glasgow, UK.

Publikováno v: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2014 Nov; Vol. 17 (7), pp. A809. Date of Electronic Publication: 2014 Oct 26.